Bone Disease Issues in Myeloma: Register Now for the Myeloma Crowd Round Table Interactive Webcast on October 10

UPCOMING MC ROUND TABLES - September 28, 2020

Making Sense of Myeloma Bone Issues   Register Now   Bone pain is often the first symptom myeloma patients experience—often before t... Read More

FDA Grants Priority Review for Ide-Cel CAR T Therapy

In a recent press release, Bristol Myers Squibb and bluebird bio announced that the FDA has accepted the new drug application for ide-cel (idecabtagene vicleuce... Read More

MCRT Webcast: Myeloma Therapies on the Horizon (BLENREP and CELMoDs)

Research and approval of drug treatments for myeloma continues to move forward, despite the limitations imposed by the pandemic, increasing options, improving q... Read More

Building Community through Activity

MUSCLES FOR MYELOMA - September 24, 2020

We are almost to the goal with our  Muscles4Myeloma September Blood Cancer Awareness month. We are excited to announce that with over 485 participants, we ... Read More

Myeloma Coaches Offer Caregiver Support

MYELOMA COACH - September 24, 2020

September is Blood Cancer Awareness month.  It is a great time to spread awareness about blood cancers including multiple myeloma. Many individuals ha... Read More

HealthTree University: Starting Treatment (Part 3 of 3)

HEALTHTREE - September 24, 2020

Below are some video excerpts from our HealthTree University curriculum to help you learn more about these important areas of your disease. By creating a Health... Read More

How Pomalidomide Works to Kill Multiple Myeloma

MYELOMA 101 - September 23, 2020

The immunomodulators (thalidomide, lenalidomide and pomalidomide) are a staple class of drugs regularly used in myeloma care. Pomalidomide is often used on... Read More

MCRT Webcast: Myeloma Genetics with Three Experts

MC ROUND TABLES - September 22, 2020

Knowing about genetics is not just for scientists anymore.  To be an informed myeloma patient it is essential to know what your specific genetic markers ar... Read More

Exercise and Mental Health

MUSCLES FOR MYELOMA - September 22, 2020

September is Blood Cancer Awareness Month. To celebrate the Month, the Myeloma Crowd is running a 30 day Muscles4Myeloma Fitness Challenge. Get moving... Read More

FDA Grants Orphan Drug Status to New CD38 Antibody Redirecting Molecule (ARM) Myeloma Therapy

MYELOMA NEWS - September 18, 2020

The FDA has granted Orphan Drug designation to a new type of myeloma therapy called an Antibody Redirecting Molecule (ARM) targeting CD38. The orphan drug ... Read More

MRD Negativity is Better than Stringent Complete Response (sCR) to Determine Myeloma Patient Outcomes

MYELOMA NEWS - September 17, 2020

In a head-to-head study comparing minimal residual disease (MRD) testing vs. using the "stringent complete response" measurement, MRD indicated a more... Read More

Finding Balance with New Routines

LIFE WITH MYELOMA - September 17, 2020

September is Blood Cancer Awareness Month. To celebrate the Month, the Myeloma Crowd is running a 30 day Muscles4Myeloma Fitness Challenge. Get moving... Read More

HealthTree University: Starting Treatment (Part 2 of 3)

HEALTHTREE - September 17, 2020

There is so much to learn when you're starting myeloma treatment! How do you choose a transplant, induction therapy, consolidation therapy, maintenance ther... Read More

Find Myeloma Help

Myeloma Financial Resource


Find financial resources like housing, prescription and patient assistance programs and other helpful links that will guide you through your myeloma care.

Myeloma Specialist


Patients who are seen by myeloma specialists live longer. Find a myeloma specialists closest to you and add them to your care team for your best outcomes.

Myeloma Clinical Trials


Find personally relevant treatment options and clinical trials at every stage of your myeloma with HealthTree and SparkCures.

Myeloma Coach


We're a team of myeloma patient and caregiver volunteers who can help you find and use the best myeloma resources so you can better navigate your myeloma care.

Thanks to our site sponsors: